Cargando…
Nectin-4 as Blood-Based Biomarker Enables Detection of Early Ovarian Cancer Stages
SIMPLE SUMMARY: Ovarian cancer is usually diagnosed in an advanced stage of the disease and is associated with a poor prognosis. Therefore, it is important to find reliable biomarkers that allow early diagnosis. In this study, we detected elevated Nectin-4 and HB-EGF serum levels in ovarian cancer p...
Autores principales: | Rogmans, Christoph, Feuerborn, Julia, Treeck, Leonie, Tribian, Nils, Flörkemeier, Inken, Arnold, Norbert, Weimer, Jörg Paul, Maass, Nicolai, Jansen, Peer, Lieb, Wolfgang, Dempfle, Astrid, Bauerschlag, Dirk O., Hedemann, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739558/ https://www.ncbi.nlm.nih.gov/pubmed/36497350 http://dx.doi.org/10.3390/cancers14235867 |
Ejemplares similares
-
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids
por: Hedemann, Nina, et al.
Publicado: (2021) -
Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer
por: Flörkemeier, Inken, et al.
Publicado: (2022) -
Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non‐invasive vaginal swab
por: Weimer, Jörg, et al.
Publicado: (2023) -
ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer
por: Rogmans, Christoph, et al.
Publicado: (2021) -
High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer
por: Flörkemeier, Inken, et al.
Publicado: (2021)